Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients

NCT03587714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2018-07-16

No results posted yet for this study

Summary

Egypt has the highest prevalence of hepatitis C virus (HCV) in the world. In 2015, the prevalence of HCV RNA was found to be 7.0%.(1) The prevalence of HCV was studied in Rheumatoid arthritis in few studies(2,3), but to our knowledge, no previous work studied it in other rheumatologic diseases.

Conditions

  • Hepatitis C

Interventions

DIAGNOSTIC_TEST

HCV RT-PCR

HCV ribonucleic acid by reverse transcriptase polymerase chain reaction (RT-PCR)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Manal Hassanien, MD · Assiut University

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-12-01
Completion
2018-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03587714 on ClinicalTrials.gov